Immunome, Inc. · 4 hours ago
Director/Associate Director, Regulatory Affairs CMC
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. They are seeking a Director/Associate Director, Regulatory Affairs CMC, responsible for developing and executing global regulatory CMC strategies and managing key deliverables while ensuring compliance with regulatory requirements.
BiopharmaBiotechnologyMedicalPharmaceutical
Responsibilities
Develop and execute global regulatory CMC strategies across clinical and commercial stages
Serve as the regulatory CMC lead on cross-functional teams, providing strategic input to technical operations, supply chain, quality and project teams
Author, review and manage the preparation of high-quality CMC sections for regulatory submission (e.g. IND, CTAs, IMPD, annual reports, pediatric plans, amendments, and marketing applications)
Lead interactions with global health authorities on CMC topics, including preparation of briefing packages, responses to information requests, and representation at meetings
Collaborate with internal and external stakeholders to ensure regulatory compliance and alignment with regulatory CMC strategies
Maintain current knowledge of regulations and guidelines (e.g., ICH, FDA, EMA) and keep abreast of changes in the global regulatory environment
Support regulatory inspections, as required
Qualification
Required
Bachelor's degree in a relevant scientific discipline
A minimum of 7 years of relevant pharmaceutical/biotechnology industry experience
5+ years in regulatory CMC
Hands-on experience with CMC submission preparation for small molecules, biologics, and/or antibody-drug conjugates
Experience with regulatory CMC strategy development and health authority interactions
Deep understanding of ICH, FDA and EMA guidelines
Outstanding communication, analytical, organizational and time management skills
Strong written and verbal communication abilities with attention to detail
Ability to effectively lead cross-functional teams
Flexible work style with a pragmatic approach to rapidly changing priorities
Proficiency in submission management software, such as Veeva RIM
Preferred
Advanced degree
Company
Immunome, Inc.
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients.
Funding
Current Stage
Public CompanyTotal Funding
$998.85MKey Investors
JPEO-CBRNDU.S. Department of DefenseRobin Hood Ventures
2025-12-16Post Ipo Equity· $400M
2025-01-29Post Ipo Equity· $150M
2024-02-13Post Ipo Equity· $230M
Recent News
2026-01-09
BioWorld Financial Watch
2025-12-19
thefly.com
2025-12-18
Company data provided by crunchbase